We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Arbor Pharma to Acquire XenoPort

News   May 24, 2016

 
Arbor Pharma to Acquire XenoPort
 
 
 

RELATED ARTICLES

$11M Study to Jumpstart Radiation Exposure Drug Development

News

The U.S. Department of Defense has turned to the University of Nebraska to jumpstart the development of drug therapies to protect military service members from the effects of radiation exposure.

READ MORE

Hindering Melanoma Metastasis with FDA-approved Drug

News

An FDA-approved drug has been identified that, when used with surgery, hampers metastasis in an animal model. Originally developed and approved ~65 years ago to control blood pressure, the medication resperine also prevents what are known as tumor-derived extracellular vesicles from fusing to healthy cells and sharing their cargo of disease-promoting molecules.

READ MORE

Altering Stathmin2 Expression Rescues Motor Neuron Growth

News

Research led by stem cell scientists at Harvard University points to a potential new biomarker and drug target for amyotrophic lateral sclerosis (ALS), a neurological disease that is difficult to diagnose and treat.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE